Sign in
Stories
Legal Actions Shake Markets
Share
Assertio Holdings Faces Securities Law I...
Legal Battles and Dismissals: Corporate ...
Securities Class Actions Amid Allegation...
AlloVir Class Action Lawsuit Filed
Altimmune Faces Investor Investigation
Amylyx Pharmaceuticals Faces Lawsuit
Overview
API
Several companies, including BioNTech SE and Amylyx Pharmaceuticals, are facing class action lawsuits due to alleged misleading statements and improper practices. Archer-Daniels-Midland Company is accused of inaccurate growth reporting. Molecular Partners AG announced the dismissal of a class action complaint against the company.
Ask a question
Could these lawsuits trigger regulatory changes in the industry to prevent similar occurrences in the future?
How might these legal challenges affect the reputation and market value of the companies involved?
What measures can companies take to ensure transparency and avoid potential legal pitfalls?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage